ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Ophthalmology

Top Ophthalmology Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DOUGLAS DAY M.D.

Ophthalmology

10,219

$932K

1401
1253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 59%

$91
Average prescription price

Avg: $72

DAVID KIM M.D.

Ophthalmology

8,328

$398K

987
868 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 59%

$48
Average prescription price

Avg: $72

JING DONG M.D.

Ophthalmology

6,903

$506K

1471
1234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

65%
prescriptions for brand name drugs

Avg: 59%

$73
Average prescription price

Avg: $72

SCOTT PASTOR MD

Ophthalmology

6,461

$457K

976
901 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

53%
prescriptions for brand name drugs

Avg: 59%

$71
Average prescription price

Avg: $72

JOHNNY GAYTON M.D.

Ophthalmology

5,764

$441K

945
793 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 59%

$76
Average prescription price

Avg: $72

JOON KIM M.D.

Ophthalmology

5,487

$393K

1105
960 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 2%

34%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 59%

$72
Average prescription price

Avg: $72

RANDALL OZMENT M.D.

Ophthalmology

5,129

$301K

666
564 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

53%
prescriptions for brand name drugs

Avg: 59%

$59
Average prescription price

Avg: $72

ROBERT HARBIN MD

Ophthalmology

4,952

$268K

974
847 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 59%

$54
Average prescription price

Avg: $72

REAY BROWN MD

Ophthalmology

4,945

$234K

810
761 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 59%

$47
Average prescription price

Avg: $72

BRADLEY JACOBY M.D.

Ophthalmology

4,933

$284K

874
737 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 59%

$58
Average prescription price

Avg: $72

HERBERT FECHTER MD

Ophthalmology

4,887

$283K

800
708 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 59%

$58
Average prescription price

Avg: $72

THOMAS HARBIN MD

Ophthalmology

4,803

$274K

658
598 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 59%

$57
Average prescription price

Avg: $72

MARKESH MANOCHA M.D.

Ophthalmology

4,765

$350K

889
739 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 59%

$73
Average prescription price

Avg: $72

MICHAEL MAGBALON MD

Ophthalmology

4,628

$318K

658
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

55%
prescriptions for brand name drugs

Avg: 59%

$69
Average prescription price

Avg: $72

ROBERT GOETZINGER M.D.

Ophthalmology

4,527

$356K

581
453 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 59%

$79
Average prescription price

Avg: $72

ALLEN BECK

Ophthalmology

4,182

$318K

478
408 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 59%

$76
Average prescription price

Avg: $72

JOSEPH BERG MD

Ophthalmology

4,179

$223K

914
834 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 2%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 59%

$53
Average prescription price

Avg: $72

BRIAN LONG MD

Ophthalmology

4,090

$261K

844
792 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

49%
prescriptions for brand name drugs

Avg: 59%

$64
Average prescription price

Avg: $72

EL-ROY DIXON M.D.

Ophthalmology

4,085

$350K

631
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 59%

$86
Average prescription price

Avg: $72

SHUNAI JIANG M.D. & PH.D.

Ophthalmology

3,846

$296K

538
483 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 59%

$77
Average prescription price

Avg: $72

FELICITY QUANSAH M.D.

Ophthalmology

3,828

$218K

509
363 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

54%
prescriptions for brand name drugs

Avg: 59%

$57
Average prescription price

Avg: $72

PAUL MCMANUS M.D.

Ophthalmology

3,767

$206K

594
559 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 59%

$55
Average prescription price

Avg: $72

SHIH YIN KAO M.D.

Ophthalmology

3,754

$274K

805
729 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 59%

$73
Average prescription price

Avg: $72

BRADLEY BERTRAM M.D.

Ophthalmology

3,741

$280K

779
723 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 59%

$75
Average prescription price

Avg: $72

BRET CRUMPTON D.O.

Ophthalmology

3,723

$415K

488
399 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

83%
prescriptions for brand name drugs

Avg: 59%

$111
Average prescription price

Avg: $72

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank